Real-World Analysis Shows Promising Outcomes, Safety With Ibrutinib in CLL
A 2-year follow-up study showed that ibrutinib maintained efficacy and safety among patients with chronic lymphocytic leukemia, highlighting its importance in the field.
A 2-year follow-up study showed that ibrutinib maintained efficacy and safety among patients with chronic lymphocytic leukemia, highlighting its importance in the field.
In 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. As someone who has lost several family dogs…
A Japanese retrospective study identified the incidence and outcomes of arterial thromboembolism in patients with cancer.
Antibody-drug conjugates are a new type of cancer therapy that deliver cancer-killing medicine to cancer cells, avoiding healthy cells along the way.
Reviewer Training Program | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research .aacrcontent h2{ margin-top: 34px; margin-bottom: 16px; } .aacrcontent ul {list-style-image:…
The final breast cancer screening recommendation from the United States Preventive Services Task Force advises that women aged 40 should begin biennial screening.
Technique of Inferior Vena Cava Resection and Replacement During Liver Resection
For people with no family history of colon cancer or other risk factors Swedish researchers found that screening every 15 years was still protective.
Apalutamide with androgen deprivation therapy following radical prostatectomy led to a biochemical recurrence-free survival rate of 100% after 2 years among patients with high-risk prostate…
Investigators examined survival rates following autologous and allogeneic hematopoietic cell transplantation among patients from multiple racial and ethnic groups and subsequently identified persisten…
Florida Cancer Specialists & Research Institute, LLC is calling for reform in value-based oncology care modeling.